Overview
Connective tissue regeneration
Dr. Lane's laboratory effort is primarily directed toward regenerating bone and other connective tissues following injury. The laboratory utilizes animal models to simulate osseous defects both in the spine and long bones. Methods employed by the group include microsurgery, molecular biology, tissue culture, biochemical assays of bone formation, histology (undecalcified, in situ hybridization, immunohistology), quantitative radiography, biomechanical testing, and blood flow analysis.
The study of osteogenesis includes the evaluation of bone marrow and ex vivo explanted mesenchymal stem cells. Osteoconductive experiments center on biodegradable polymers, native biosynthetic and composite ceramics, and collagen based matrices. Osteoinduction uses the family of BMP growth factors as well as BFGF and TGF-ß. Bone morphogenctic protein has been studied during fracture healing by in situ hybridization and immunohistology. We have employed the use of exogenous rhBMP to heal critical defects, promote spine fusion and generate bone ossicles. In association with Dr. Weiland we are currently generating "bones to order" in silastic molds containing mesenchymal stem cells, BMP, and a vascularized pedical. These neo-bones can be moved an their vascular leash or through micro-vascular transer to replace or heal apendicular bone defects. Through viral vectors BMP and other growth factor genes have been infected into stem cells to be used regionally to repair connective tissue. The laboratory, in collaboration with Dr. Bostrom and Dr. Sandhu, is actively using BMP, osteoprogenitor cells, and a variety of osteoconductive matrices in animal and human clinical trials.
The laboratory is examining the process of injury and repair of connective tissues. By utilizing Y-chromosome and transfected cells, we are determining the origin of the specific stem cells that contribute to the various stages of tissue regeneration and differentiation. The osseous matrix of normal and metabolically altered bone is studied in collaboration with Dr. Boskey and Dr. Paschalis principally by FTIR micro-spectroscopy and collagen analysis. We are evaluating how estrogen and other gender specific hormones control the quality and amount of collagen in tendons and ligaments.
Working in collaboration with Dr. Bostrom and Dr. Nestor, the laboratory is establishing the role of various cytokines in the pathway of prosthetic loosening. We are utilzing specific bone anti-resorptive agents to inhibit the osteolytic process.
Publications
Funding
Completed grants (2)
- PIR13AR063599-012013 AAOS Bone Quality and Fracture Prevention Research SymposiumNIAMS · 2012–2013 · via NIH RePORTER
Clinical research
Active
3 studies- PIAge-Related Osteoporotic Vertebral Fracture & Kyphoplasty RegistryHospital for Special Surgery · OPEN TO ACCRUAL (as of 2025)
- PIEvaluation of Hip Fracture MortalityNew York Presbyterian Hospital · OPEN TO ACCRUAL (as of 2025)
- PINCT06455085RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturENA · University of Alabama at Birmingham · OPEN TO ACCRUAL (as of 2025)Osteoporosis; Osteoporotic Fractures; Fragility Fracture
Completed & closed trials (1)
- PINCT04249232Abaloparatide Versus Placebo for Pelvic Fracture Healing - A Phase 2 Randomized Controlled TrialPHASE2 · National Inst of Arthritis & Musculoskeletal & Skin Diseases · IRB STUDY CLOSURE (as of 2024)Fracture of Pelvis (Disorder)
Mentoring
- ZWZhaorui WangMD mentee · Class of 2023
- RSRehan SaiyedEarly career mentee · Class of 2018
- MWMark WishmanMD mentee · Class of 2024
- GGGary GeorgeMD mentee · Class of 2022
- RSRidhi SachdevMD mentee · Class of 2018